QRS after TAVI, The Best Predictor for safe transitory pacemaker removal

Original title: Patients Without Prolonged QRS After TAVI with CoreValve Device do not Experience High-Degree Atrio-Ventricular Block. Reference: Gauthier Mouillet et al. Catheterization and Cardiovascular Interventions 81:882–887 (2013).

High degree atrioventricular block (AVB) in the context of transcatheter aortic valve implantation (TAVI) has been reported with variable incidence (3-45%) depending on the population characteristics and the kind of prosthesis. This event happens immediately after TAVI only in 30% of cases, most of BAV being delayed within 7 days after implantation. The study aimed at prospectively identifying post TAVI delayed AVB predictors requiring permanent pacemaker (PP). 

104 TAVI patients were analyzed at one center between 2007 and 2011, with the CoreValve ReValving system (Medtronic, Northridge, CA). 14 patients that were not free from PP before TAVI indication and 11 patients that presented AVB immediately after TAVI were excluded; 79 patients made the final analysis. After implantation, 21 patients exhibited delayed high grade AVB (27%): 17 (80%) in the first week, 3 within 30 days and only one within 12 months. There were no significant differences in clinical baseline characteristics or ECG between those that required PP and those who did not.

Patients that developed delayed high grade AVB after TAVI presented wider QRS duration, greater prevalence of left branch block and deeper implantation; however, QRS duration immediately after TAVI was the sole independent predictor of delayed high degree AVB when performing a multivariable analysis. QRS width as predictor of delayed AVB and the resulting need of a PP had a 0.76 ROC area under the curve (p<0.001; 95% IC, 0.65-0.85) with best cut off at 148 msec, 64% sensitivity and 73% specificity. However, if cut off was lowered to 128 msec, we could achieve 100% sensitivity to predict the need of a PP, resigning some specificity. After a mean follow-up of 10 ± 8 months, patients with post-TAVI QRS ≤128 msec did not require a PP.

Conclusion: 

High degree atrioventricular block after TAVI generally requires a PP. QRS duration immediately after implantation was the best predictor of this event. Patients that presented post TAVI QRS ≤128 msec have no risk of high degree AVB block.

Editorial Comment: 

This precise cut off is relevant to the management of this patients given that a QRS ≤128 msec is not a safe indicator for transitory pacemaker early removal or for hospital discharge. On the other hand, greater duration QRS invites us to be cautious and wait longer to discharge patients, despite the fact that the patient may present optimal clinical conditions. 

SOLACI.ORG

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...